Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 1;36(4):309-313.
doi: 10.1097/BOR.0000000000001024. Epub 2024 May 2.

Investigating gout flares: beyond a definition

Affiliations
Review

Investigating gout flares: beyond a definition

Charles Sutherland et al. Curr Opin Rheumatol. .

Abstract

Purpose of review: Gout flares are a paramount component of disease burden inflicted by gout onto the patient. Furthermore, they are included in the core domain set for long-term gout studies recognized by Outcome Measures in Rheumatology. Along with a validated classification criterion for gout, gout investigators have turned their efforts into defining and characterizing the gout flare. This brief review will summarize the efforts that have been done to define and characterize a gout flare in clinical studies.

Recent findings: Recent findings include a validated definition of a gout flare that has been utilized in novel clinical studies, use of technology to monitor for gout flares and their effects on patient life, and qualitative analyses into the disease burden that a patient undergoes.

Summary: Although guidelines for core outcome domains have been well established, there is question in methods of measuring and reporting gout flares in long-term trials. Furthermore, there is question as to the effectiveness of the agreed upon instruments' abilities to fully capture the disease burden experienced by patients with gout. A combination of outcome measurements including binary data (gout flare present or absent) along with a comprehensive measurement of disease burden over time would theoretically provide a more accurate description of the disease and serve as a basis for intervention development.

PubMed Disclaimer

References

    1. Janssen CA, Oude Voshaar MAH, Ten Klooster PM, et al. Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies. Rheumatology (Oxford) 2019; 58:1928–1934.
    1. Bursill D, Taylor WJ, Terkeltaub R, et al. Gout, hyperuricemia, and crystal-associated disease network consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care Res (Hoboken) 2019; 71:427–434.
    1. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972; 15:189–192.
    1. Gaffo AL, Schumacher HR, Saag KG, et al. Developing a provisional definition of flare in patients with established gout. Arthritis Rheum 2012; 64:1508–1517.
    1. Seow LL, Jiao N, Wang W, et al. A qualitative study exploring perceptions of patients with gout. Clin Nurs Res 2020; 29:56–65.